Previous close | 5.58 |
Open | 5.56 |
Bid | 5.20 x 200 |
Ask | 5.30 x 600 |
Day's range | 5.25 - 5.56 |
52-week range | 2.13 - 7.73 |
Volume | |
Avg. volume | 625,898 |
Market cap | 253.088M |
Beta (5Y monthly) | 1.31 |
PE ratio (TTM) | 11.67 |
EPS (TTM) | 0.45 |
Earnings date | 02 May 2024 - 06 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 4.33 |
Puma Biotechnology (PBYI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
LOS ANGELES, March 20, 2024--The FDA cleared Puma Biotechnology's IND for Alisertib in HER2-negative, hormone receptor-positive metastatic breast cancer.